Medical Editor: John P. Cunha, DO, FACOEP
What Is Eysuvis?
Eysuvis (loteprednol etabonate ophthalmic suspension) is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.
What Are Side Effects of Eysuvis?
Side effects of Eysuvis include:
- instillation site pain and
- elevated intraocular pressure (may be associated with infrequent optic nerve damage, problems with sharpness of vision, cataract formation, delayed wound healing, and secondary eye infection)
Seek medical care or call 911 at once if you have the following serious side effects:
- Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
- Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheartedness, or passing out;
- Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.
This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.
Dosage for Eysuvis
The dose of Eysuvis is one to two drops instilled into each eye four times daily.
Eysuvis In Children
Safety and effectiveness of Eysuvis in pediatric patients have not been established.
What Drugs, Substances, or Supplements Interact with Eysuvis?
Eysuvis may interact with other medicines.
Tell your doctor all medications and supplements you use.
Eysuvis During Pregnancy and Breastfeeding
Tell your doctor if you are pregnant or plan to become pregnant before using Eysuvis; it is unknow how it would affect a fetus. It is unknown if Eysuvis passes into breast milk. Consult your doctor before breastfeeding.
Additional Information
Our Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25%, for Topical Ophthalmic Use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
SLIDESHOW
Pink Eye (Conjunctivitis) Symptoms, Causes, Treatments See SlideshowGet emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
- pain when using the eye drops;
- worsening redness or itching;
- eye pain or swelling, trouble closing your eye;
- pain behind your eyes, sudden vision changes;
- tunnel vision, seeing halos around lights; or
- signs of eye infection--redness, severe discomfort, crusting or drainage.
Common side effects may include:
- minor burning when using the eye drops;
- eye pain, blurred vision;
- dry or watery eyes;
- feeling like something is in your eye;
- your eyes may be more sensitive to light;
- headache; or
- runny nose, sore throat.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
QUESTION
What causes dry eyes? See AnswerSIDE EFFECTS
Adverse reactions associated with ophthalmic corticosteroids include elevated intraocular pressure, which may be associated with infrequent optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, delayed wound healing and secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera.
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The most common adverse reaction observed in clinical trials with EYSUVIS was instillation site pain, which was reported in 5% of patients.
Read the entire FDA prescribing information for Eysuvis (Loteprednol Etabonate Ophthalmic Suspension)
© Eysuvis Patient Information is supplied by Cerner Multum, Inc. and Eysuvis Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.
Health Solutions From Our Sponsors